Elutia Management

Management criteria checks 3/4

Elutia's CEO is Randy Mills, appointed in Jun 2022, has a tenure of 2.42 years. total yearly compensation is $2.05M, comprised of 29.3% salary and 70.7% bonuses, including company stock and options. directly owns 0.73% of the company’s shares, worth $1.02M. The average tenure of the management team and the board of directors is 2.8 years and 6.6 years respectively.

Key information

Randy Mills

Chief executive officer

US$2.1m

Total compensation

CEO salary percentage29.3%
CEO tenure2.4yrs
CEO ownership0.7%
Management average tenure2.8yrs
Board average tenure6.6yrs

Recent management updates

Recent updates

Elutia Inc. (NASDAQ:ELUT) Held Back By Insufficient Growth Even After Shares Climb 26%

Nov 20
Elutia Inc. (NASDAQ:ELUT) Held Back By Insufficient Growth Even After Shares Climb 26%

Elutia Inc.'s (NASDAQ:ELUT) Share Price Boosted 28% But Its Business Prospects Need A Lift Too

Jun 28
Elutia Inc.'s (NASDAQ:ELUT) Share Price Boosted 28% But Its Business Prospects Need A Lift Too

News Flash: 2 Analysts Think Elutia Inc. (NASDAQ:ELUT) Earnings Are Under Threat

Mar 10
News Flash: 2 Analysts Think Elutia Inc. (NASDAQ:ELUT) Earnings Are Under Threat

Elutia Inc.'s (NASDAQ:ELUT) Share Price Is Matching Sentiment Around Its Revenues

Feb 21
Elutia Inc.'s (NASDAQ:ELUT) Share Price Is Matching Sentiment Around Its Revenues

Little Excitement Around Aziyo Biologics, Inc.'s (NASDAQ:AZYO) Revenues As Shares Take 63% Pounding

Apr 17
Little Excitement Around Aziyo Biologics, Inc.'s (NASDAQ:AZYO) Revenues As Shares Take 63% Pounding

Aziyo Biologics appoints Williams as Chief Scientific Officer

Aug 26

Aziyo Biologics names co-founder C. Randal Mills as permanent CEO

Aug 10

CEO Compensation Analysis

How has Randy Mills's remuneration changed compared to Elutia's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$60m

Jun 30 2024n/an/a

-US$70m

Mar 31 2024n/an/a

-US$49m

Dec 31 2023US$2mUS$600k

-US$41m

Sep 30 2023n/an/a

-US$32m

Jun 30 2023n/an/a

-US$35m

Mar 31 2023n/an/a

-US$38m

Dec 31 2022US$2mUS$321k

-US$36m

Sep 30 2022n/an/a

-US$39m

Jun 30 2022n/an/a

-US$37m

Mar 31 2022n/an/a

-US$28m

Dec 31 2021US$146kn/a

-US$25m

Sep 30 2021n/an/a

-US$21m

Jun 30 2021n/an/a

-US$23m

Mar 31 2021n/an/a

-US$26m

Dec 31 2020US$142kn/a

-US$25m

Compensation vs Market: Randy's total compensation ($USD2.05M) is above average for companies of similar size in the US market ($USD646.00K).

Compensation vs Earnings: Randy's compensation has been consistent with company performance over the past year.


CEO

Randy Mills (52 yo)

2.4yrs

Tenure

US$2,050,887

Compensation

Dr. C. Randal Mills, Ph D., also known as Randy, has been Director of Elutia Inc. (formerly known as Aziyo Biologics, Inc.) since November 2015. Dr. Mills serves as a Member of Advisory Board at eXpanded e...


Leadership Team

NamePositionTenureCompensationOwnership
C. Mills
Co-Founder2.4yrsUS$2.05m0.73%
$ 1.0m
Matthew Ferguson
Chief Financial Officer4.2yrsUS$521.08k0.90%
$ 1.2m
Michelle Williams
Chief Scientific Officer2.3yrsUS$485.97k0.17%
$ 239.4k
Courtney Guyer
Vice President of Marketing6.8yrsno datano data
Sonali Fonseca
VP & Head of Emerging Businesses2.8yrsno datano data
Jeffry Hamet
Senior VP of Financeno datano datano data

2.8yrs

Average Tenure

52yo

Average Age

Experienced Management: ELUT's management team is considered experienced (2.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
C. Mills
Co-Founder9yrsUS$2.05m0.73%
$ 1.0m
Kevin Rakin
Independent Chairman & Lead Independent Director9yrsUS$254.61k0.26%
$ 363.2k
Brigid Makes
Independent Director4.2yrsUS$116.41k0.0058%
$ 8.0k
Matt Zuga
Independent Director9yrsUS$80.99k0%
$ 0
Maybelle Jordan
Independent Director4.2yrsUS$96.41k0%
$ 0
David Colpman
Independent Director2.1yrsUS$93.91k0%
$ 0

6.6yrs

Average Tenure

63yo

Average Age

Experienced Board: ELUT's board of directors are considered experienced (6.6 years average tenure).